ADELIN分析:子宫腺肌症的存在及其对母体、新生儿和产科结局的影响:系统综述与Meta分析
该系统综述与Meta分析纳入39项研究(5,521,417例患者,其中25,564例子宫腺肌症),评估子宫腺肌症对母体、新生儿及产科结局的影响。结果显示子宫腺肌症与子痫前期、产后出血、小于胎龄儿、胎位异常、流产、未足月胎膜早破、胎盘位置异常、极早产、低出生体重及先兆早产风险升高相关,但证据确定性低至极低。结论认为子宫腺肌症可能增加不良母体、产科及新生儿结局风险,临床医生应意识到这些可能增加的风险,以实施针对性产前监测、调整妊娠管理并优化孕前咨询。
要点
- 子宫腺肌症与子痫前期风险升高相关(RR 2.24,95%CI 1.34-3.75;I²=72.6%;低确定性)。
- 子宫腺肌症与胎盘位置异常风险升高相关(RR 3.26,95%CI 2.76-3.86;I²=0%;低确定性)。
- 证据确定性低至极低,需高质量研究证实;临床医生应意识到这些可能增加的风险。
核心结论
- 子宫腺肌症可能增加不良母体、产科及新生儿结局风险,但证据确定性低至极低。
- 需高质量研究证实现有发现;临床医生应意识到这些可能增加的风险,以实施针对性产前监测、调整妊娠管理并优化子宫腺肌症女性的孕前咨询。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南,使用随机效应模型报告相对风险及95%置信区间。
- 检索MEDLINE、Scopus、Embase、LILACS、SciELO、Cochrane、ClinicalTrials.gov、CINAHL、PsycINFO、AMED及灰色文献至当前日期,无限制。
- 纳入比较子宫腺肌症女性与无子宫腺肌症女性母体、新生儿和/或产科结局的研究。
- 共纳入39项研究,5,521,417例患者,其中25,564例子宫腺肌症。
- 使用ROBINS-E工具评估偏倚风险,采用GRADE方法评定证据确定性;按受孕方式行亚组分析。
主要发现
- 子宫腺肌症与子痫前期风险升高相关(RR 2.24,95%CI 1.34-3.75;I²=72.6%;低确定性)。
- 子宫腺肌症与产后出血风险升高相关(RR 1.73,95%CI 1.2-2.49;I²=63.9%;低确定性)。
- 子宫腺肌症与小于胎龄儿风险升高相关(RR 1.79,95%CI 1.34-2.39;I²=74.7%;低确定性)。
- 子宫腺肌症与胎位异常风险升高相关(RR 1.95,95%CI 1.29-2.93;I²=77.7%;低确定性)。
- 子宫腺肌症与流产风险升高相关(RR 1.61,95%CI 1.31-1.99;I²=82.99%;低确定性)。
关键数值与推荐
- 子宫腺肌症与子痫前期风险升高相关(RR 2.24,95%CI 1.34-3.75;I²=72.6%;低确定性)。
- 子宫腺肌症与产后出血风险升高相关(RR 1.73,95%CI 1.2-2.49;I²=63.9%;低确定性)。
- 子宫腺肌症与小于胎龄儿风险升高相关(RR 1.79,95%CI 1.34-2.39;I²=74.7%;低确定性)。
- 子宫腺肌症与胎位异常风险升高相关(RR 1.95,95%CI 1.29-2.93;I²=77.7%;低确定性)。
- 子宫腺肌症与流产风险升高相关(RR 1.61,95%CI 1.31-1.99;I²=82.99%;低确定性)。
临床怎么用
- 作者认为,临床医生应意识到子宫腺肌症女性这些可能增加的风险,以实施针对性产前监测、调整妊娠管理并优化孕前咨询。
- 作者指出,需高质量研究证实现有发现。
局限性
- 证据确定性低至极低。
- 需高质量研究证实现有发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically review and quantify the impact of adenomyosis on maternal, neonatal, and obstetric outcomes. DATA SOURCES: A comprehensive, unrestricted search was conducted in MEDLINE, Scopus, Embase, Literatura Latino-Americana e do Caribe em Ciências da Saúde, Scientific Electronic Library Online, Cochrane, ClinicalTrials.gov, Cumulative Index to Nursing and Allied Health Literature, Psychological Information Database, Allied and Complementary Medicine Database, and gray literature up to the present date. STUDY ELIGIBILITY CRITERIA: Studies were selected if they compared maternal, neonatal, and/or obstetric outcomes in women with adenomyosis compared to those without adenomyosis. METHODS: Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed to carry out meta-analyses using random-effects models reporting relative risks and 95% confidence intervals. The Risk Of Bias In Nonrandomized Studies-of Exposure tool and the Grading of Recommendations, Assessment, Development, and Evaluations methodology were used to rate the risk of bias and evidence certainty. Subgroup analysis was carried out by dividing studies according to the mode of conception. RESULTS: Thirty-nine studies (5,521,417 patients; 25,564 with adenomyosis) showed that adenomyosis was associated with increased risks of preeclampsia (relative risk, 2.24; 95% confidence interval, 1.34-3.75; I2=72.6%, low certainty), postpartum hemorrhage (relative risk, 1.73; 95% confidence interval, 1.2-2.49; I2=63.9%, low certainty), small for gestational age (relative risk, 1.79; 95% confidence interval, 1.34-2.39; I2=74.7%, low certainty), fetal malpresentation (relative risk, 1.95; 95% confidence interval, 1.29-2.93; I2=77.7%, low certainty), miscarriage (relative risk, 1.61; 95% confidence interval, 1.31-1.99; I2=82.99%, low certainty), preterm premature rupture of membranes (relative risk, 2.87; 95% confidence interval, 1.37-6.0; I2=35.2%, low certainty), placental malposition (relative risk, 3.26; 95% confidence interval, 2.76-3.86; I2=0%, low certainty), extreme preterm birth (relative risk, 3.71; 95% confidence interval, 1.75-7.88; I2=88.5%, low certainty), low birthweight (relative risk, 2.29; 95% confidence interval, 1.24-4.24; I2=91.5%, low certainty), and threatened preterm labor (relative risk, 1.54; 95% confidence interval, 1.37-1.73; very low certainty), although certainty of evidence was low to very low. No significant differences were observed for gestational diabetes, HELLP syndrome, uterine rupture, fetal growth restriction, fetal distress, intrauterine death, ectopic pregnancy, multiple pregnancy, premature rupture of membranes, Apgar <7, umbilical artery pH <7, or neonatal intensive care admission. CONCLUSION: Adenomyosis may be associated with increased risks of adverse maternal, obstetric, and neonatal outcomes; however, certainty of evidence was low to very low. While high-quality studies are needed to corroborate available findings, clinicians should be aware of these plausible increased risks to implement targeted prenatal surveillance, tailor pregnancy management, and optimize preconception counselling for women with adenomyosis.
引用
- Etrusco A, Agrifoglio V, D'Amato A, et al. The ADELIN analysis: the presence of ADenomyosis and its effects on matErnal, neonataL, and obstetrIc outcomes: a systematic review and meta-aNalysis. Am J Obstet Gynecol. 2025. PMID: 41232787. doi:10.1016/j.ajog.2025.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。